why choose us

First received: June 06, 2023

Clinical Trial: This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atopic Dermatitis Eczema

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of ANB032 in the Treatment of Subjects With Moderate to Severe Atopic Dermatitis

Brief Summary: This study will evaluate the safety, tolerability, and efficacy of ANB032 in subjects with moderate to severe atopic dermatitis (AD).

Read more